119 related articles for article (PubMed ID: 33793092)
1. Effect of transfer from a pediatric to adult cystic fibrosis center on clinical status and hospital attendance.
Collins R; Singh B; Payne DN; Bharat C; Noffsinger W; Dhaliwal SS; O'Dea C; Mulrennan S
Pediatr Pulmonol; 2021 Jul; 56(7):2029-2035. PubMed ID: 33793092
[TBL] [Abstract][Full Text] [Related]
2. Health outcomes associated with transition from pediatric to adult cystic fibrosis care.
Tuchman L; Schwartz M
Pediatrics; 2013 Nov; 132(5):847-53. PubMed ID: 24144711
[TBL] [Abstract][Full Text] [Related]
3. Clinical changes of patients with cystic fibrosis during transition from pediatric to adult care.
Duguépéroux I; Tamalet A; Sermet-Gaudelus I; Le Bourgeois M; Gérardin M; Desmazes-Dufeu N; Hubert D
J Adolesc Health; 2008 Nov; 43(5):459-65. PubMed ID: 18848674
[TBL] [Abstract][Full Text] [Related]
4. A formalized transition program for cystic fibrosis: A 10-year retrospective analysis of 97 patients in Lyon.
Bourgeois G; Magne F; Nove Josserand R; Durupt S; Durieu I; Reix P; Reynaud Q
Pediatr Pulmonol; 2021 Jul; 56(7):2000-2006. PubMed ID: 33751837
[TBL] [Abstract][Full Text] [Related]
5. Smoothing the transition of adolescents with CF from pediatric to adult care: Pre-transfer needs.
Genovese VV; Perceval M; Buscarlet-Jardine L; Pinsault N; Gauchet A; Allenet B; Llerena C
Arch Pediatr; 2021 May; 28(4):257-263. PubMed ID: 33863608
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United States.
Sawicki GS; Ostrenga J; Petren K; Fink AK; D'Agostino E; Strassle C; Schechter MS; Rosenfeld M
Ann Am Thorac Soc; 2018 Feb; 15(2):234-240. PubMed ID: 29220199
[TBL] [Abstract][Full Text] [Related]
7. Transitioning from paediatric to adult services with cystic fibrosis or bronchiectasis: What is the impact on engagement and health outcomes?
Moss R; Farrant B; Byrnes CA
J Paediatr Child Health; 2021 Apr; 57(4):548-553. PubMed ID: 33185946
[TBL] [Abstract][Full Text] [Related]
8. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
9. Long term azithromycin therapy in patients with cystic fibrosis.
Emiralioğlu N; Öztürk Z; Yalçın E; Doğru D; Özçelik U; Kiper N
Turk J Pediatr; 2016; 58(1):34-40. PubMed ID: 27922234
[TBL] [Abstract][Full Text] [Related]
10. Transition programs in cystic fibrosis centers: perceptions of pediatric and adult program directors.
Flume PA; Anderson DL; Hardy KK; Gray S
Pediatr Pulmonol; 2001 Jun; 31(6):443-50. PubMed ID: 11389577
[TBL] [Abstract][Full Text] [Related]
11. Impact of social complexity on outcomes in cystic fibrosis after transfer to adult care.
Crowley EM; Bosslet GT; Khan B; Ciccarelli M; Brown CD
Pediatr Pulmonol; 2018 Jun; 53(6):735-740. PubMed ID: 29611352
[TBL] [Abstract][Full Text] [Related]
12. Children with bronchiectasis have poorer lung function than those with cystic fibrosis and do not receive the same standard of care.
Prentice BJ; Wales S; Doumit M; Owens L; Widger J
Pediatr Pulmonol; 2019 Dec; 54(12):1921-1926. PubMed ID: 31475469
[TBL] [Abstract][Full Text] [Related]
13. Transition program from pediatric to adult care for cystic fibrosis patients.
Nasr SZ; Campbell C; Howatt W
J Adolesc Health; 1992 Dec; 13(8):682-5. PubMed ID: 1290768
[TBL] [Abstract][Full Text] [Related]
14. Perspectives of patients with cystic fibrosis on preventive counseling and transition to adult care.
Zack J; Jacobs CP; Keenan PM; Harney K; Woods ER; Colin AA; Emans SJ
Pediatr Pulmonol; 2003 Nov; 36(5):376-83. PubMed ID: 14520719
[TBL] [Abstract][Full Text] [Related]
15. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
16. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
Epidemiol Prev; 2021; 45(3 Suppl 1):1-37. PubMed ID: 34132083
[TBL] [Abstract][Full Text] [Related]
17. Transition programs in cystic fibrosis centers: perceptions of team members.
Flume PA; Taylor LA; Anderson DL; Gray S; Turner D
Pediatr Pulmonol; 2004 Jan; 37(1):4-7. PubMed ID: 14679482
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations.
Cogen JD; Oron AP; Gibson RL; Hoffman LR; Kronman MP; Ong T; Rosenfeld M
Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28126911
[TBL] [Abstract][Full Text] [Related]
19. Enteral tube feeding in adults with cystic fibrosis; patient choice and impact on long term outcomes.
White H; Morton AM; Conway SP; Peckham DG
J Cyst Fibros; 2013 Dec; 12(6):616-22. PubMed ID: 23770301
[TBL] [Abstract][Full Text] [Related]
20. Increased rate of lung function decline in Australian adolescents with cystic fibrosis.
Welsh L; Robertson CF; Ranganathan SC
Pediatr Pulmonol; 2014 Sep; 49(9):873-7. PubMed ID: 24178906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
